Additionally, the reported role in breast cancer of fetal mammary developmental genes, such as TBX3, WNT-10b, FGF10, and LEF1, highlights their potential clinical relevance as biomarkers and therapeutic targets. Here, FGF10 is linked to breast carcinoma.